Browsing Category
Personalized Medicine
11 posts
Revolutionizing Cancer Treatment: Personalized Vaccines Near Clinical Use
What is the message? Personalized cancer vaccines, which target the unique mutations of individual tumors, are poised to…
Revolutionizing Cancer Treatment: Personalized Cell-Based Therapies and Their Impact
the health strategistinstitute for strategic health transformation & digital technology Joaquim Cardoso MSc. Chief Research and Strategy Officer (CRSO),Chief Editor and…
The next generation of evidence-based medicine — Deep Medicine, AI enabled
“Every major disease needs a ‘Moonshot’ program and every rare disease should have an ‘Operation Warp Speed” This is…
Using Data to Live Longer, Healthier Lives — [the case for scientific wellness]
Health Transformation Institute (HTI) digital, health and care transformation Joaquim Cardoso MScFounder and Chief Researcher, Editor and AdvisorDecember…
CRISPR cancer trial success paves the way for personalized treatments
Health & Care Transformation Institute (HCTI) Joaquim Cardoso MSc*Chief Strategy Officer, Researcher and EditorNovember 11, 2022 *MSc from London…
64% of potentially eligible patients with Cancer (NSCLC) are not benefiting from precision oncology (Non-Small-Cell Lung Cancer)
Chief Researcher and Editor: Joaquim Cardoso MScthe health transformation / journalNovember 2, 2022 This is a republication of the…
The cancer moonshot of Biontech — 1.5 billion euros investment in 2022
This is a republication of the article below, with the title above. What BioNTech did next: the plan…
Personalised prescribing: using pharmacogenomics — Chapter #1 Introduction – “The case for a Pharmacogenomic Approach”
A pharmacogenomic approach, where genetic variation informs choice of drug and dose, can facilitate greater precision in prescribing…
The pandemic has forced to redirect clinical trials to be more patient-centric than before
This is a republication of the paper “The next generation of evidence-based medicine — Deep Medicine, AI enabled”, with the…
Biomarker development has facilitated progress in clinical trial design, with unprecedented advances in genomics and immunology
This is a republication of the paper “The next generation of evidence-based medicine — Deep Medicine, AI enabled”, with the…
